ES2181132T3 - Derivados de benzo(b)tiofeno para disminuir el contenido de plaquetas. - Google Patents

Derivados de benzo(b)tiofeno para disminuir el contenido de plaquetas.

Info

Publication number
ES2181132T3
ES2181132T3 ES98306570T ES98306570T ES2181132T3 ES 2181132 T3 ES2181132 T3 ES 2181132T3 ES 98306570 T ES98306570 T ES 98306570T ES 98306570 T ES98306570 T ES 98306570T ES 2181132 T3 ES2181132 T3 ES 2181132T3
Authority
ES
Spain
Prior art keywords
plates
thiophen
benzo
derivatives
decrease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98306570T
Other languages
English (en)
Inventor
Mark Chandrakant Lakshmanan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2181132T3 publication Critical patent/ES2181132T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

SE PRESENTA UNA PREPARACION DE UNA FORMULACION FARMACEUTICA PARA HACER DESCENDER CON SEGURIDAD EL NUMERO DE PLAQUETAS EN UN HUMANO QUE UTILIZA UN COMPUESTO DE LA FORMULA (I) EN LA R SUP,1 Y R 3 SON, INDEPENDIENTEMENTE, -H, -CH 3 , -CO (ALQUIL C 1-C 6 ), O -COAR, EN DONDE AR ES FENILO OPCIONALMENTE SUSTITUIDO; R 3 SE SELECCIONA ENTRE EL GRUPO QUE CONSTA DE PIRROLIDINA, PIPERIDINA, Y HEXAMETILENEIMINO; TAMBIEN SE PRESENTAN LAS SALES O SOLVATOS FARMACOLOGICAMENTE ACEPTABLES DEL COMPUESTO.
ES98306570T 1997-08-21 1998-08-18 Derivados de benzo(b)tiofeno para disminuir el contenido de plaquetas. Expired - Lifetime ES2181132T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5620397P 1997-08-21 1997-08-21

Publications (1)

Publication Number Publication Date
ES2181132T3 true ES2181132T3 (es) 2003-02-16

Family

ID=22002873

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98306570T Expired - Lifetime ES2181132T3 (es) 1997-08-21 1998-08-18 Derivados de benzo(b)tiofeno para disminuir el contenido de plaquetas.

Country Status (22)

Country Link
US (1) US6103740A (es)
EP (1) EP0904783B1 (es)
JP (1) JP2001515015A (es)
KR (1) KR20010023075A (es)
CN (1) CN1275886A (es)
AT (1) ATE220905T1 (es)
AU (1) AU741882B2 (es)
BR (1) BR9811962A (es)
CA (1) CA2301806A1 (es)
DE (1) DE69806705T2 (es)
DK (1) DK0904783T3 (es)
EA (1) EA001582B1 (es)
ES (1) ES2181132T3 (es)
HR (1) HRP20000094A2 (es)
HU (1) HUP0002715A3 (es)
IL (1) IL134551A0 (es)
NO (1) NO20000750L (es)
NZ (1) NZ502842A (es)
PL (1) PL338700A1 (es)
PT (1) PT904783E (es)
TR (1) TR200000453T2 (es)
WO (1) WO1999008525A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9624800D0 (en) * 1996-11-29 1997-01-15 Lilly Co Eli Methods of preventing breast cancer
US6353003B1 (en) 1998-06-17 2002-03-05 Eli Lilly And Company Method for reducing levels of homocysteine and C-reactive protein
US6585995B1 (en) * 1999-09-21 2003-07-01 Hanson Stephen R Methods and compositions for treating platelet-related disorders
US20090092693A1 (en) * 2007-10-05 2009-04-09 Mady Attila Platelet manipulation to prevent and treat endovascular disease and its sequelae, to prevent and treat arrhythmias and to prevent malignancy
US8021854B2 (en) * 2007-10-05 2011-09-20 Attila Mady Method of treating vascular disease

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4447620A (en) * 1982-06-08 1984-05-08 The Upjohn Company Imidazolyl-substituted benzothiophenes
US5075321A (en) * 1987-03-24 1991-12-24 University Of Pennsylvania Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
US4847276A (en) * 1988-09-06 1989-07-11 Merrell Dow Pharmaceuticals Inc. Treatment of thromobocytosis with 5-(4-chlorophenyl)-2,4-diemthyl-3H-1,2,4-triazole-3-thione
JPH0517357A (ja) * 1991-07-05 1993-01-26 Nissan Chem Ind Ltd 血小板減少療法剤
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
US5424334A (en) * 1991-12-19 1995-06-13 G. D. Searle & Co. Peptide mimetic compounds useful as platelet aggregation inhibitors
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
US5445941A (en) * 1993-06-21 1995-08-29 Eli Lilly And Company Method for screening anti-osteoporosis agents
US5391557A (en) * 1993-10-15 1995-02-21 Eli Lilly And Company Methods for the treatment of peri-menopausal syndrome
US5441965A (en) * 1993-12-21 1995-08-15 Eli Lilly And Company Methods of inhibiting thrombin
US5476862A (en) * 1993-12-21 1995-12-19 Eli Lilly And Company Methods of increasing thrombomodulin expression
US6025373A (en) * 1997-04-22 2000-02-15 Eli Lilly And Company Methods for reducing fibrinogen

Also Published As

Publication number Publication date
NO20000750L (no) 2000-04-13
HRP20000094A2 (en) 2000-08-31
DE69806705T2 (de) 2003-03-20
HUP0002715A2 (hu) 2001-06-28
BR9811962A (pt) 2000-08-15
EP0904783B1 (en) 2002-07-24
AU741882B2 (en) 2001-12-13
EA200000243A1 (ru) 2000-10-30
US6103740A (en) 2000-08-15
ATE220905T1 (de) 2002-08-15
IL134551A0 (en) 2001-04-30
CN1275886A (zh) 2000-12-06
NZ502842A (en) 2001-11-30
PL338700A1 (en) 2000-11-20
WO1999008525A1 (en) 1999-02-25
EP0904783A1 (en) 1999-03-31
HUP0002715A3 (en) 2002-12-28
KR20010023075A (ko) 2001-03-26
DE69806705D1 (de) 2002-08-29
DK0904783T3 (da) 2002-09-02
TR200000453T2 (tr) 2000-08-21
CA2301806A1 (en) 1999-02-25
NO20000750D0 (no) 2000-02-15
JP2001515015A (ja) 2001-09-18
EA001582B1 (ru) 2001-06-25
PT904783E (pt) 2002-10-31
AU8830698A (en) 1999-03-08

Similar Documents

Publication Publication Date Title
NO2016005I1 (no) 2-okso-1-pyrrolidinderivater, farmasøytisk preparat og deres anvendelse for fremstilling av et medikament
AR001332A1 (es) Nuevos compuestos antagonistas de la taquicinina, proceso para obtenerlos y composiciones farmaceuticas que los contienen.
EE200300033A (et) Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
SE8804629D0 (sv) New therapeutically active compounds
AR020001A1 (es) COMPUESTOS ACTIVADORES DE hPPARGAMMA Y hPPARALFA, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN, METODO PARA EL TRATAMIENTO Y/O PREVENCION DE UNAENFERMEDAD MEDIADA POR LOS MISMOS, Y SU USO PARA LA ELABORACION DE UN MEDICAMENTO
SE9504661D0 (sv) New compounds
AR029174A1 (es) Derivados de espirooxindol, proceso para su preparacion, formulacion farmaceutica, y utilizacion de los derivados en la manufactura de medicamentos
MX9700693A (es) Derivados del 4-indol.
CO5271700A1 (es) Composicion farmaceutica que comprende acido 3-[2,4-dimetil-5-(2-oxo-1,2-dihidro-indol-3-ilidenmetil)-1h-pirrol-3-il]-propionico, uno o mas compuestos polihidrocarbilo y un vehiculo farmaceuticamente aceptable
ES2160640T3 (es) Nuevos (r)-5-carbamoil-8-fluoro-3-amino disustituido en n,n-3,4-dihidro-2h-1-benzopiranos.
ES2160648T3 (es) Derivados de piridina.
AR024998A1 (es) Nuevos retinoides para el tratamiento del enfisema
DE69713300D1 (de) Benzopyran derivate mit leukotrien-antagonistischer wirkung
ES2193233T3 (es) Uso de amiodipina, una sal de la misma o felodipina en combinacion con un inhibidor ace en la fabricacion de un medicamento para el tratamiento de insuficiencia cardiaca conjuntiva no isquemica.
ES2181132T3 (es) Derivados de benzo(b)tiofeno para disminuir el contenido de plaquetas.
FR2680172B1 (fr) Nouvelles piperazinylalcoyl-3 dihydro-2,3 4h-benzoxazine-1,3 ones-4 substituees, leur preparation et leur application en therapeutique.
ES2066390T3 (es) Nuevos derivados del espiro-(4.5)-decano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
TR200200473T2 (tr) Rar selektif retinoid agonistleri.
ES2145234T3 (es) Derivados de la diosmetina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
AR045912A1 (es) Composiciones farmaceuticas que contienen derivados de azetidina
AR006281A1 (es) Utilizacion de (+)-alfa-(2,3-dimetoxifenil)-1-[2-(4-fluorofenil)etil]-4- piperidinometanol o sus sales de adicion de acidos farmaceuticamenteaceptables en el tratamineto de trastornos depresivos y trastornos bipolares
EE04058B1 (et) Benso[c]kinolisiini derivaadid, nende valmistamine ja kasutamine 5a-reduktaasi inhibiitoritena
SE9504662D0 (sv) New compounds
ES2192789T3 (es) Derivados de hidrazono-benzazuleno, composiciones farmaceuticas y compuestos intermedios.
UY27001A1 (es) Derivados de la indolilpiperidina como agentes antihistamínicos y antialérgicos